[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-334764-105":59,"doc-detail-334764-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","prognostic-roles-of-inflammatory-biomarkers-in-radioiodine-refractory-thyroid-cancer-treated-with-lenvatinib","Prognostic Roles of Inflammatory Biomarkers in Radioiodine-Refractory Thyroid Cancer Treated with Lenvatinib","","Inflammatory biomarkers, including the neutrophil-to-lymphocyte ratio (NLR), lymphocyte-to-monocyte ratio (LMR), and platelet-to-lymphocyte ratio (PLR), are evaluated as prognostic indicators in radioiodine-refractory thyroid cancer treated with lenvatinib. A multicenter retrospective cohort study analyzed baseline biomarkers in 71 patients using available pre-treatment complete blood counts. Progression-free survival (PFS) and overall survival (OS) were assessed against median biomarker values. Higher-than-median NLR predicted shorter PFS and OS and remained linked to poor OS in multivariate analysis; LMR and PLR showed distinct associations with OS.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/prognostic-roles-of-inflammatory-biomarkers-in-radioiodine-refractory-thyroid-cancer-treated-with-lenvatinib/334764/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/prognostic-roles-of-inflammatory-biomarkers-in-radioiodine-refractory-thyroid-cancer-treated-with-lenvatinib/334764.png","ImageObject",300,407,{"name":92,"@type":93},"Aurora","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",11,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What inflammatory biomarkers were assessed as prognostic indicators?","Question",{"text":113,"@type":114},"The study assessed NLR, LMR, and PLR using complete blood counts collected before lenvatinib treatment.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How did a higher baseline NLR affect patient outcomes?",{"text":118,"@type":114},"Patients with a higher-than-median NLR had significantly shorter progression-free survival and overall survival, and higher NLR was also associated with poor overall survival in multivariate analysis.",{"name":120,"@type":111,"acceptedAnswer":121},"Were LMR and PLR associated with progression-free survival?",{"text":122,"@type":114},"No. The study reported that neither LMR nor PLR was associated with progression-free survival; their associations were specific to overall survival.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},334764,1790012752,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":52,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":4},4810365810221,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Original Article  \nEndocrinol Metab 2024;39:334-343 [https://doi.org/10.3803/EnM.2023.1854](https://doi.org/10.3803/EnM.2023.1854)[ ](https://doi.org/10.3803/EnM.2023.1854)[pISSN 2093-596X](pISSN 2093-596X) · eISSN 2093-5978  \nPrognostic Roles of Inflammatory Biomarkers in Radioiodine-Refractory Thyroid Cancer Treated with Lenvatinib  \nChaeA Kim1, Mijin Kim2,3, Meihua Jin1,4, Hee Kyung Kim5, Min Ji Jeon 1, Dong Jun Lim6, Bo Hyun Kim2,3, Ho-Cheol Kang5, Won Bae Kim1, DongYeob Shin7, Won Gu Kim 1  \n1Division of Endocrinology and Metabolism, Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul; 2Department of Internal Medicine, Pusan National University School of Medicine, Yangsan; 3Biomedical Research Institute, Pusan National University Hospital, Busan; 4Division of Endocrinology and Metabolism, Department of Internal Medicine, Dankook University College of Medicine, Cheonan; 5Department of Internal Medicine, Chonnam National University Medical School, Gwangju; 6Division of Endocrinology and Metabolism, Department of Internal Medicine, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea; 7Division of Endocrinology and Metabolism, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea  \nBackground: Inflammatory biomarkers, such as the neutrophil-to-lymphocyte ratio (NLR), lymphocyte-to-monocyte ratio (LMR), and platelet-to-lymphocyte ratio (PLR), serve as valuable prognostic indicators in various cancers. This multicenter, retrospective cohort study assessed the treatment outcomes of lenvatinib in 71 patients with radioactive iodine (RAI)-refractory thyroid cancer, considering the baseline inflammatory biomarkers.  \nMethods: This study retrospectively included patients from five tertiary hospitals in Korea whose complete blood counts were available before lenvatinib treatment. Progression-free survival (PFS) and overall survival (OS) were evaluated based on the median value of inflammatory biomarkers.  \nResults: No significant differences in baseline characteristics were observed among patients grouped according to the inflammatory biomarkers, except for older patients with a higher-than-median NLR (≥2) compared to their counterparts with a lower NLR (P = 0.01). Patients with a higher-than-median NLR had significantly shorter PFS (P = 0.02) and OS (P = 0.017) than those with a lower NLR. In multivariate analysis, a higher-than-median NLR was significantly associated with poor OS (hazard ratio, 3.0; 95% confidence interval, 1.24 to 7.29; P = 0.015). However, neither the LMR nor the PLR was associated with PFS. A higher-than-median LMR (≥3.9) was significantly associated with prolonged OS compared to a lower LMR (P = 0.036). In contrast, a higher-than-median PLR (≥142.1) was associated with shorter OS compared to a lower PLR (P = 0.039).  \nReceived: 12 October 2023, Revised: 14 December 2023, Accepted: 29 January 2024  \nCorresponding authors: Won Gu Kim  \nDivision of Endocrinology and Metabolism, Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul 05505, Korea  \nTel: +82-2-3010-5883, Fax: +82-2-3010-6962, [E-mail:](E-mail: wongukim@amc.seoul.kr)[ wongukim@amc.seoul.kr](E-mail: wongukim@amc.seoul.kr)  \nDongYeob Shin  \nDivision of Endocrinology and Metabolism, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, Korea  \nTel: +82-2-228-2261, Fax: +82-2-393-6884, E-mail: [shindongyi@yuhs.ac](shindongyi@yuhs.ac)  \nCopyright © 2024 Korean Endocrine Society  \nThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ([https://creativecommons.org/](https://creativecommons.org/)[ ](https://creativecommons.org/)[licenses/by-nc/4.0/](licenses/by-nc/4.0/)) [which permits unrestricted non-commercial","cbCaipu9FA7iQvLt","https://ap.wps.com/l/cbCaipu9FA7iQvLt","pdf",394141,"English","# Background\n# Methods\n# Results\n## NLR findings\n## LMR and PLR findings\n# Conclusion\n# Introduction","[{\"question\":\"What inflammatory biomarkers were assessed as prognostic indicators?\",\"answer\":\"The study assessed NLR, LMR, and PLR using complete blood counts collected before lenvatinib treatment.\"},{\"question\":\"How did a higher baseline NLR affect patient outcomes?\",\"answer\":\"Patients with a higher-than-median NLR had significantly shorter progression-free survival and overall survival, and higher NLR was also associated with poor overall survival in multivariate analysis.\"},{\"question\":\"Were LMR and PLR associated with progression-free survival?\",\"answer\":\"No. The study reported that neither LMR nor PLR was associated with progression-free survival; their associations were specific to overall survival.\"}]","Prognostic Roles of Inflammatory Biomarkers in Radioiodine-Refractory Thyroid Cancer Treated with Lenvatinib | PDF",1790008265,25]